EUVIMEDEUVIMED entdecken
Crossref

Pharmaco-Epigenomic response of Pimozide is mediated through miR-2909

Deepti Malik, Ashvinder Raina iD, Jitender Singh, Hitaishi Kaushik, Gurjeet Kaur, Seema Bansal, Phulen Sarma, Ashish Jain, Bikash Medhi

Integrative Biology · 16.01.2026 · 18

DOI: 10.1093/intbio/zyag008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Integrative Biology, online erschienen am 08.06.2026. Verfasst von Deepti Malik und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, AIIMS, Bilaspur, Himachal Pradesh, 174001, India. Hauptthemen laut MEDLINE: MicroRNAs, Pimozide, Epigenesis, Genetic. Die Arbeit nennt 42 Literaturangaben. Gefördert von: ICMR, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A recent study delves into intricate relationship between microRNAs (miRNAs), specifically focusing on their role in cancer development. miRNAs are highlighted for their capacity to modify genetic profile and modulate epigenetic architecture, establishing regulatory circuit between epigenetic modulation and miRNAs. Notably, antipsychotic drugs, particularly pimozide, is reported to influence miRNA expression, impacting essential processes in cancer development such as cell proliferation and apoptosis. Anti-cancer properties of pimozide have sparked interest in its potential role in cancer treatment, although precise mechanism of its antitumor function remains elusive. The study focuses on a newly discovered miRNA, miR-2909, encoded by the apoptosis antagonizing transcription factor (AATF) gene, which has been implicated in oncogenesis. This research aims to unravel the interplay between pimozide and miR-2909, investigating their influence on epigenetic modulations and their functional relevance to cellular proliferation and apoptosis in cancer cells. Utilizing bioinformatic tools for structural prediction, pharmacokinetic property assessment, and molecular docking interactions, the study reveals a strong binding affinity between pimozide and miR-2909.Validation through various experimental methods, including qRT-PCR, western blotting, immunofluorescence, transient transfection, CHIP assay, and flow cytometry confirms the interplay between pimozide and miR-2909. The results demonstrate a pivotal role in the regulation of genes responsible for cellular proliferation and apoptosis. Additionally, the study uncovers that pimozide’s pharmaco-epigenomic response is mediated through miR-2909, promoting DNA methylation and leading to decreased cellular proliferation, increased apoptosis, ROS generation, and altered cell-cycle dynamics. In conclusion, the findings identify pimozide as a potential chemotherapeutic agent acting through the regulation of the oncomiR-2909. Insight Box This study uncovers a novel pharmaco-epigenomic mechanism by which the antipsychotic drug pimozide exerts anti-cancer effects in breast and lung cancer cells. We demonstrate that pimozide downregulates oncogenic miR-2909, leading to the upregulation of DNMT3B, which mediates epigenetic silencing of key proliferation genes and promotes apoptosis. This integrative approach—combining molecular biology, gene expression profiling, and epigenetic analysis—provides new biological insight into the repurposing of psychiatric drugs for cancer therapy. Our findings highlight the therapeutic potential of targeting microRNA-epigenetic interactions and suggest a broader applicability of integrating pharmacology with systems biology to uncover unconventional roles of known drugs in cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsPimozideEpigenesis, GeneticHumansApoptosisCell ProliferationCell Line, TumorGene Expression Regulation, NeoplasticAntipsychotic AgentsMolecular Docking SimulationEpigenomicsAntineoplastic Agents

Stichwörter der Autor:innen

Pimozideantipsychotic drugscancerflow-cytometermiR-2909pharmaco-epigenomic

Substanzen

MicroRNAsPimozideAntipsychotic AgentsAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Biochemistry, AIIMS, Bilaspur, Himachal Pradesh, 174001, India.
  • Department of Histopathology, SS Anand Block, PGIMER, Sector 12, Chandigarh, 160012, India.
  • Department of Biophysics, Chhuttani Block, PGIMER, Sector 12, Chandigarh, 160012, India.
  • Department of Dermatology & Venerology, Chhuttani Block, PGIMER, Sector 12, Chandigarh, 160012, India.
  • Department of Pharmacology, Chhuttani Block, PGIMER, Sector 12, Chandigarh, 160012, India.
  • Department of Pharmacology, MM College of Pharmacy, Mulana, Ambala, Haryana, 133207, India.

ORCID-Profile: Ashvinder Raina

Förderung

  • ICMR, India

Zitieren

APA

Malik, D., Raina, A., Singh, J., Kaushik, H., Kaur, G., Bansal, S., Sarma, P., Jain, A., & Medhi, B. (2026). Pharmaco-Epigenomic response of Pimozide is mediated through miR-2909. Integrative Biology, 18. https://doi.org/10.1093/intbio/zyag008

Vancouver

Malik D, Raina A, Singh J, Kaushik H, Kaur G, Bansal S, et al. Pharmaco-Epigenomic response of Pimozide is mediated through miR-2909. Integrative Biology. 2026;18. doi:10.1093/intbio/zyag008

BibTeX
@article{Malik2026,
  author = {Malik, Deepti and Raina, Ashvinder and Singh, Jitender and Kaushik, Hitaishi and Kaur, Gurjeet and Bansal, Seema and Sarma, Phulen and Jain, Ashish and Medhi, Bikash},
  title = {Pharmaco-Epigenomic response of Pimozide is mediated through miR-2909},
  journal = {Integrative Biology},
  year = {2026},
  volume = {18},
  doi = {10.1093/intbio/zyag008}
}
Kostenlos starten →